30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Neurogene Inc (NGNE)

Track

Over the last 90 days, Neurogene Inc. has seen significant insider selling, with a net value of -$147,438.62. Executives have been the primary sellers, with a net value of -$147,438.62. Notable transactions include multiple sales by Christine Cvijic and Rachel McMinn, occurring in March and May 2026. No insider purchases were recorded.
Stock chart
Ticker: NGNE Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Cvijic Christine Mikail
President and CFO
2 sales — total 300,043 USD
Planned sale 6 May 2026
Value US$4,515,770.82 | Price 384.20 | Shares 76,017
Planned sale 6 May 2026
Value US$1,991,511.79 | Price 73.34 | Shares 68,363
Proposed sale 6 May 2026
Value US$2,861,583.94 | Price 26.02 | Shares 23,592
Sale 26 Mar 2026
Value US$55,315.98 | Price 21.62 | Shares 2,558
Sale 26 Mar 2026
Value US$73,995.06 | Price 22.07 | Shares 3,352
Sale 26 Mar 2026
Value US$18,127.57 | Price 21.89 | Shares 828
Planned sale 13 Mar 2026
Value US$3,267.84 | Price 22.08 | Shares 148
Planned sale 13 Mar 2026
Value US$56,721.72 | Price 21.34 | Shares 2,658
Planned sale 13 Mar 2026
Value US$81,456.31 | Price 20.41 | Shares 3,991
Sale 13 Mar 2026
Value US$5,791.13 | Price 22.02 | Shares 263
Sale 13 Mar 2026
Value US$29,636.91 | Price 21.25 | Shares 1,395
Sale 13 Mar 2026
Value US$48,748.27 | Price 20.42 | Shares 2,387
Proposed sale 13 Mar 2026
Value US$151,573.10 | Price 22.30 | Shares 6,797
Planned sale 27 Feb 2026
Value US$120,526.08 | Price 25.11 | Shares 4,800
Proposed sale 27 Feb 2026
Value US$188,928.00 | Price 19.68 | Shares 9,600
Planned sale 14 May 2025
Value US$103,003.10 | Price 15.15 | Shares 6,797
Proposed sale 14 May 2025
Value US$105,421.47 | Price 15.51 | Shares 6,797
Sale 13 Mar 2025
Value US$76,246.94 | Price 16.94 | Shares 4,501
Buy 26 Nov 2024
Value US$55,000.00 | Price 27.50 | Shares 2,000
Buy 26 Nov 2024
Value US$406,803.87 | Price 26.73 | Shares 15,219
Buy 26 Nov 2024
Value US$280,986.03 | Price 26.01 | Shares 10,803
Buy 26 Nov 2024
Value US$516,832.68 | Price 24.91 | Shares 20,748
Buy 22 Nov 2024
Value US$969,000.00 | Price 20.40 | Shares 47,500
Buy 22 Nov 2024
Value US$491,400.00 | Price 20.48 | Shares 24,000
Proposed sale 7 Mar 2024
Value US$98,234.25 | Price 39.29 | Shares 2,500
Proposed sale 4 Mar 2024
Value US$13,567.28 | Price 36.57 | Shares 371
Proposed sale 9 Feb 2024
Value US$77,500.00 | Price 31.00 | Shares 2,500
Proposed sale 6 Feb 2024
Value US$76,125.00 | Price 30.45 | Shares 2,500
Buy 17 Aug 2023
Value US$42,353.64 | Price 0.69 | Shares 61,134
Buy 17 Aug 2023
Value US$3,492.40 | Price 0.69 | Shares 5,041
Buy 17 Aug 2023
Value US$64,456.21 | Price 0.69 | Shares 93,091
Buy 17 Aug 2023
Value US$5,314.86 | Price 0.69 | Shares 7,676
Buy 16 Aug 2023
Value US$3,027.54 | Price 0.68 | Shares 4,434
Buy 16 Aug 2023
Value US$249.90 | Price 0.68 | Shares 366
Buy 16 Aug 2023
Value US$141,323.52 | Price 0.68 | Shares 207,676
Buy 16 Aug 2023
Value US$11,652.88 | Price 0.68 | Shares 17,124
Buy 15 Aug 2023
Value US$2,887.43 | Price 0.67 | Shares 4,342
Buy 15 Aug 2023
Value US$238.07 | Price 0.67 | Shares 358
Buy 15 Aug 2023
Value US$1,097,958.49 | Price 0.63 | Shares 1,740,581
Buy 15 Aug 2023
Value US$90,531.79 | Price 0.63 | Shares 143,519
Planned sale 11 Aug 2023
Value US$818.14 | Price 0.62 | Shares 1,323
Sale 3 Apr 2023
Value US$2,607.77 | Price 0.69 | Shares 3,769
Sale 2 Feb 2023
Value US$1,980.32 | Price 0.60 | Shares 3,316
Planned sale 2 Feb 2023
Value US$8,587.74 | Price 0.60 | Shares 14,380
Sale 10 Aug 2022
Value US$1,640.77 | Price 0.99 | Shares 1,655
Planned sale 2 May 2022
Value US$6,748.61 | Price 1.22 | Shares 5,538
Planned sale 16 Jun 2021
Value US$6,114.00 | Price 10.19 | Shares 600
Planned sale 9 Jun 2021
Value US$7,035.99 | Price 10.82 | Shares 650
Planned sale 8 Jun 2021
Value US$6,600.00 | Price 11.00 | Shares 600
Buy 4 Jun 2021
Value US$96,082.00 | Price 9.61 | Shares 10,000
Buy 3 Jun 2021
Value US$379,272.00 | Price 9.48 | Shares 40,000
Planned sale 26 May 2021
Value US$6,000.00 | Price 10.00 | Shares 600
Planned sale 19 May 2021
Value US$6,378.00 | Price 10.63 | Shares 600
Planned sale 12 May 2021
Value US$13,308.00 | Price 11.09 | Shares 1,200
Planned sale 5 May 2021
Value US$13,560.00 | Price 11.30 | Shares 1,200
Planned sale 28 Apr 2021
Value US$30,192.00 | Price 12.58 | Shares 2,400
Planned sale 26 Apr 2021
Value US$7,800.00 | Price 13.00 | Shares 600
Planned sale 21 Apr 2021
Value US$21,564.00 | Price 11.98 | Shares 1,800
Planned sale 14 Apr 2021
Value US$21,996.00 | Price 12.22 | Shares 1,800
Planned sale 7 Apr 2021
Value US$21,636.00 | Price 12.02 | Shares 1,800
Planned sale 5 Apr 2021
Value US$7,800.00 | Price 13.00 | Shares 600
Planned sale 31 Mar 2021
Value US$21,528.00 | Price 11.96 | Shares 1,800
Planned sale 24 Mar 2021
Value US$21,515.94 | Price 11.95 | Shares 1,800
Planned sale 22 Mar 2021
Value US$7,200.00 | Price 12.00 | Shares 600
Sale 17 Mar 2021
Value US$71,556.01 | Price 11.01 | Shares 6,497
Planned sale 17 Mar 2021
Value US$13,632.00 | Price 11.36 | Shares 1,200
Planned sale 10 Mar 2021
Value US$21,540.06 | Price 11.97 | Shares 1,800
Planned sale 3 Mar 2021
Value US$21,360.06 | Price 11.87 | Shares 1,800
Planned sale 25 Feb 2021
Value US$7,800.00 | Price 13.00 | Shares 600
Planned sale 24 Feb 2021
Value US$21,852.00 | Price 12.14 | Shares 1,800
Planned sale 17 Feb 2021
Value US$30,480.00 | Price 12.70 | Shares 2,400
Planned sale 10 Feb 2021
Value US$42,600.00 | Price 14.20 | Shares 3,000
Planned sale 5 Feb 2021
Value US$8,400.00 | Price 14.00 | Shares 600
Planned sale 3 Feb 2021
Value US$31,752.00 | Price 13.23 | Shares 2,400
Buy 7 Jul 2020
Value US$6,013,990.00 | Price 15.25 | Shares 394,360
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-08 2026-05-06 PlS Planned sale
2.2
Cvijic Christine Mikail

President and CFO

Executive Director
76,017 +19.5%
384.20
US$4,515,771 		76,017 +19.5% 384.20 US$4,515,771
2026-05-08 2026-05-06 PlS Planned sale
2.2
Cvijic Christine Mikail

President and CFO

Executive Director
68,363 +30.6%
73.34
US$1,991,512 		68,363 +30.6% 73.34 US$1,991,512
2026-05-06 2026-05-06 PrS Proposed sale
2.2
Christine Cvijic

Officer

Officer
23,592
26.02
US$2,861,584 		23,592 26.02 US$2,861,584
2026-03-30 2026-03-26 S Sale
2.2
Cvijic Christine Mikail

President and CFO

Officer
2,558 -2.4%
21.62
US$55,316 		2,558 -2.4% 21.62 US$55,316
2026-03-30 2026-03-26 S Sale
1.9
McMinn Rachel

Chief Executive Officer

Executive Director
3,352 -0.2%
22.07
US$73,995 		3,352 -0.2% 22.07 US$73,995
2026-03-30 2026-03-26 S Sale
2.0
Jordan Julie

Chief Medical Officer

Officer
828 -6.2%
21.89
US$18,128 		828 -6.2% 21.89 US$18,128
2026-03-17 2026-03-13 PlS Planned sale
Cobb Stuart

Chief Scientific Officer

Officer
148 -0.5%
22.08
US$3,268 		148 -0.5% 22.08 US$3,268
2026-03-17 2026-03-13 PlS Planned sale
Cobb Stuart

Chief Scientific Officer

Officer
2,658 -8.0%
21.34
US$56,722 		2,658 -8.0% 21.34 US$56,722
2026-03-17 2026-03-13 PlS Planned sale
Cobb Stuart

Chief Scientific Officer

Officer
3,991 -10.7%
20.41
US$81,456 		3,991 -10.7% 20.41 US$81,456
2026-03-17 2026-03-13 S Sale
2.2
Cvijic Christine Mikail

President and CFO

Officer
263 -0.2%
22.02
US$5,791 		263 -0.2% 22.02 US$5,791
2026-03-17 2026-03-13 S Sale
2.2
Cvijic Christine Mikail

President and CFO

Officer
1,395 -1.3%
21.25
US$29,637 		1,395 -1.3% 21.25 US$29,637
2026-03-17 2026-03-13 S Sale
2.2
Cvijic Christine Mikail

President and CFO

Officer
2,387 -2.2%
20.42
US$48,748 		2,387 -2.2% 20.42 US$48,748
2026-03-13 2026-03-13 PrS Proposed sale
STUART COBB

Officer

Officer
6,797
22.30
US$151,573 		6,797 22.30 US$151,573
2026-03-03 2026-02-27 PlS Planned sale
2.2
Cvijic Christine Mikail

President and CFO

Officer
4,800 -4.2%
25.11
US$120,526 		4,800 -4.2% 25.11 US$120,526
2026-02-27 2026-02-27 PrS Proposed sale
2.2
Christine Cvijic

Officer

Officer
9,600
19.68
US$188,928 		9,600 19.68 US$188,928
2025-05-15 2025-05-14 PlS Planned sale
Cobb Stuart

Chief Scientific Officer

Officer
6,797 -24.6%
15.15
US$103,003 		6,797 -24.6% 15.15 US$103,003
2025-05-14 2025-05-14 PrS Proposed sale
STUART COBB

Officer

Officer
6,797
15.51
US$105,421 		6,797 15.51 US$105,421
2025-03-17 2025-03-13 S Sale
2.2
Cvijic Christine Mikail

President and CFO

Officer
4,501 -5.9%
16.94
US$76,247 		4,501 -5.9% 16.94 US$76,247
2024-11-27 2024-11-26 B Purchase
3.6
Samsara BioCapital GP, LLC
Large shareholder
2,000 +0.1%
27.50
US$55,000 		2,000 +0.1% 27.50 US$55,000
2024-11-27 2024-11-26 B Purchase
3.6
Samsara BioCapital GP, LLC
Large shareholder
15,219 +0.9%
26.73
US$406,804 		15,219 +0.9% 26.73 US$406,804
2024-11-27 2024-11-26 B Purchase
3.6
Samsara BioCapital GP, LLC
Large shareholder
10,803 +0.6%
26.01
US$280,986 		10,803 +0.6% 26.01 US$280,986
2024-11-27 2024-11-26 B Purchase
3.6
Samsara BioCapital GP, LLC
Large shareholder
20,748 +1.2%
24.91
US$516,833 		20,748 +1.2% 24.91 US$516,833
2024-11-25 2024-11-22 B Purchase
1.9
McMinn Rachel

Chief Executive Officer

Executive Director
47,500 +3.8%
20.40
US$969,000 		47,500 +3.8% 20.40 US$969,000
2024-11-25 2024-11-22 B Purchase
2.2
Cvijic Christine Mikail

President and CFO

Officer
24,000 +45.4%
20.48
US$491,400 		24,000 +45.4% 20.48 US$491,400
2024-03-07 2024-03-07 PrS Proposed sale
0.5
MARTIN BABLER

Director

Non-Executive Director
2,500
39.29
US$98,234 		2,500 39.29 US$98,234
2024-03-04 2024-03-04 PrS Proposed sale
2.4
SEAN SMITH

Officer

Officer
371
36.57
US$13,567 		371 36.57 US$13,567
2024-02-09 2024-02-09 PrS Proposed sale
2.1
TODD SIMPSON

Director

Non-Executive Director
2,500
31.00
US$77,500 		2,500 31.00 US$77,500
2024-02-06 2024-02-06 PrS Proposed sale
ERIN LAVELLE

Director

Non-Executive Director
2,500
30.45
US$76,125 		2,500 30.45 US$76,125
2023-08-17 2023-08-17 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
61,134 +1.1%
0.69
US$42,354 		61,134 +1.1% 0.69 US$42,354
2023-08-17 2023-08-17 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
5,041 +1.0%
0.69
US$3,492 		5,041 +1.0% 0.69 US$3,492
2023-08-17 2023-08-17 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
93,091 +1.7%
0.69
US$64,456 		93,091 +1.7% 0.69 US$64,456
2023-08-17 2023-08-17 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
7,676 +1.6%
0.69
US$5,315 		7,676 +1.6% 0.69 US$5,315
2023-08-17 2023-08-16 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
4,434 +0.1%
0.68
US$3,028 		4,434 +0.1% 0.68 US$3,028
2023-08-17 2023-08-16 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
366 +0.1%
0.68
US$250 		366 +0.1% 0.68 US$250
2023-08-17 2023-08-16 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
207,676 +4.0%
0.68
US$141,324 		207,676 +4.0% 0.68 US$141,324
2023-08-17 2023-08-16 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
17,124 +3.7%
0.68
US$11,653 		17,124 +3.7% 0.68 US$11,653
2023-08-17 2023-08-15 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
4,342 +0.1%
0.67
US$2,887 		4,342 +0.1% 0.67 US$2,887
2023-08-17 2023-08-15 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
358 +0.1%
0.67
US$238 		358 +0.1% 0.67 US$238
2023-08-17 2023-08-15 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
1,740,581 +49.7%
0.63
US$1,097,958 		1,740,581 +49.7% 0.63 US$1,097,958
2023-08-17 2023-08-15 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
143,519 +44.8%
0.63
US$90,532 		143,519 +44.8% 0.63 US$90,532
2023-08-14 2023-08-11 PlS Planned sale
2.4
Smith Sean Michael

Interim CFO, Prin Acct Off

Officer
1,323 -5.8%
0.62
US$818 		1,323 -5.8% 0.62 US$818
2023-04-04 2023-04-03 S Sale
1.3
Patel Priti

Former Chief Medical Officer
3,769 -9.2%
0.69
US$2,608 		3,769 -9.2% 0.69 US$2,608
2023-02-03 2023-02-02 S Sale
2.4
Smith Sean Michael

Principal Accounting Officer

Officer
3,316 -17.2%
0.60
US$1,980 		3,316 -17.2% 0.60 US$1,980
2023-02-03 2023-02-02 PlS Planned sale
1.3
Patel Priti

Chief Medical Officer

Officer
14,380 -31.6%
0.60
US$8,588 		14,380 -31.6% 0.60 US$8,588
2022-08-12 2022-08-10 S Sale
2.4
Smith Sean Michael

Principal Accounting Officer

Officer
1,655 -19.6%
0.99
US$1,641 		1,655 -19.6% 0.99 US$1,641
2022-05-03 2022-05-02 PlS Planned sale
1.3
Patel Priti

Chief Medical Officer

Officer
5,538 -46.2%
1.22
US$6,749 		5,538 -46.2% 1.22 US$6,749
2021-06-17 2021-06-16 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
600 -0.0%
10.19
US$6,114 		600 -0.0% 10.19 US$6,114
2021-06-11 2021-06-09 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
650 -0.0%
10.82
US$7,036 		650 -0.0% 10.82 US$7,036
2021-06-09 2021-06-08 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
600 -0.0%
11.00
US$6,600 		600 -0.0% 11.00 US$6,600
2021-06-07 2021-06-04 B Purchase
2.8
DRACHMAN JONATHAN G

President and CEO

Executive Director
10,000 +0.4%
9.61
US$96,082 		10,000 +0.4% 9.61 US$96,082
2021-06-07 2021-06-03 B Purchase
2.8
DRACHMAN JONATHAN G

President and CEO

Executive Director
40,000 +1.8%
9.48
US$379,272 		40,000 +1.8% 9.48 US$379,272
2021-05-26 2021-05-26 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
600 -0.0%
10.00
US$6,000 		600 -0.0% 10.00 US$6,000
2021-05-21 2021-05-19 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
600 -0.0%
10.63
US$6,378 		600 -0.0% 10.63 US$6,378
2021-05-12 2021-05-12 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
1,200 -0.1%
11.09
US$13,308 		1,200 -0.1% 11.09 US$13,308
2021-05-06 2021-05-05 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
1,200 -0.1%
11.30
US$13,560 		1,200 -0.1% 11.30 US$13,560
2021-04-30 2021-04-28 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
2,400 -0.2%
12.58
US$30,192 		2,400 -0.2% 12.58 US$30,192
2021-04-27 2021-04-26 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
600 -0.0%
13.00
US$7,800 		600 -0.0% 13.00 US$7,800
2021-04-22 2021-04-21 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
1,800 -0.1%
11.98
US$21,564 		1,800 -0.1% 11.98 US$21,564
2021-04-16 2021-04-14 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
1,800 -0.1%
12.22
US$21,996 		1,800 -0.1% 12.22 US$21,996
2021-04-08 2021-04-07 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
1,800 -0.1%
12.02
US$21,636 		1,800 -0.1% 12.02 US$21,636
2021-04-06 2021-04-05 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
600 -0.0%
13.00
US$7,800 		600 -0.0% 13.00 US$7,800
2021-04-02 2021-03-31 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
1,800 -0.1%
11.96
US$21,528 		1,800 -0.1% 11.96 US$21,528
2021-03-24 2021-03-24 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
1,800 -0.1%
11.95
US$21,516 		1,800 -0.1% 11.95 US$21,516
2021-03-24 2021-03-22 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
600 -0.0%
12.00
US$7,200 		600 -0.0% 12.00 US$7,200
2021-03-18 2021-03-17 S Sale
2.2
Ho Robert

Chief Financial Officer

Officer
6,497 -23.2%
11.01
US$71,556 		6,497 -23.2% 11.01 US$71,556
2021-03-18 2021-03-17 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
1,200 -0.1%
11.36
US$13,632 		1,200 -0.1% 11.36 US$13,632
2021-03-11 2021-03-10 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
1,800 -0.1%
11.97
US$21,540 		1,800 -0.1% 11.97 US$21,540
2021-03-04 2021-03-03 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
1,800 -0.1%
11.87
US$21,360 		1,800 -0.1% 11.87 US$21,360
2021-02-25 2021-02-25 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
600 -0.0%
13.00
US$7,800 		600 -0.0% 13.00 US$7,800
2021-02-25 2021-02-24 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
1,800 -0.1%
12.14
US$21,852 		1,800 -0.1% 12.14 US$21,852
2021-02-18 2021-02-17 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
2,400 -0.2%
12.70
US$30,480 		2,400 -0.2% 12.70 US$30,480
2021-02-12 2021-02-10 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
3,000 -0.2%
14.20
US$42,600 		3,000 -0.2% 14.20 US$42,600
2021-02-09 2021-02-05 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
600 -0.0%
14.00
US$8,400 		600 -0.0% 14.00 US$8,400
2021-02-05 2021-02-03 PlS Planned sale
Walkey Carl

Senior Vice President

Officer
2,400 -0.2%
13.23
US$31,752 		2,400 -0.2% 13.23 US$31,752
2020-12-23 2020-07-07 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director
394,360 +12.7%
15.25
US$6,013,990 		394,360 +12.7% 15.25 US$6,013,990
Explore more

More insider trading research around Neurogene Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America